PDCD1LG2 and neoplasm: In the present study, we show that the therapeutic efficacy of anti-PDL1 and anti-PDL2 Abs can be significantly enhanced by the timely administration of immunogenic chemotherapy and that the effectiveness of this combination is proportional to the inherent immunogenicity of the tumor.